SCHEMBL4609213

SCHEMBL4609213

N[C@@H](CO)C(=O)Nc1ccc2ccccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
MAPT P10636 3/20 0.55
POLB P06746 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
RAB9A P51151 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
GAA P10253 1/20 0.54
NPC1 O15118 3/20 0.53
CYP1A2 P05177 3/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP2C19 P33261 1/20 0.53
HIF1A Q16665 1/20 0.53
ROCK2 O75116 2/20 0.49
LMNA P02545 4/20 0.49
CMA1 P23946 1/20 0.49
SLC1A3 P43003 1/20 0.49
SLC1A2 P43004 1/20 0.49
SLC1A1 P43005 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25266534 1.00 MEN1 (0.55) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL30427471 1.00 MEN1 (0.55) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL28635019 0.86 MAPT (0.62) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL30932805 0.86 MAPT (0.54) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL15465921 0.86 MAPT (0.62) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL9393008 0.85 RAB9A (0.55) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL30485178 0.85 LTA4H (0.60) MEN1KMT2AMAPTPOLBL3MBTL1
Hydrochloric Acid SCHEMBL30337968 0.85 MAPT (0.53) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL1614525 0.84 BACE1 (0.54) MEN1KMT2AMAPTPOLBL3MBTL1
SCHEMBL5145729 0.84 BACE1 (0.54) MEN1KMT2AMAPTPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127144-A PRODUCING HETEROLOGOUS PROTEINS BY INCUBATING STREPTOMYCES CELL TRANSFORMED WITH NUCLEIC ACID EXPRESSION CONSTRUCT IN PRESENCE OF PEPTIDE-SUSBSTITUTED CHLOROMETHYLKETONE AMINOPEPTIDASE INHIBITOR HAVING DEFINED STRUCTURE CANGENE CORPORATION (CA) 2000-10-03 US claimed
EP-0122151-B1 PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE MEITO SANGYO KABUSHIKI KAISHA (JP) 1989-02-15 EP claimed
US-4783402-A Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1988-11-08 US claimed
EP-0165905-A1 Diagnostic assay method for the detection of oral pathogenic bacteria mixtures THE BOARD OF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1985-12-27 EP claimed
EP-0122151-A2 Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1984-10-17 EP claimed
US-4208480-A Method, reagents and apparatus for the rapid identification of Neisseria gonorrhoeae and Neisseria meningitidis AMERICAN HOME PRODUCTS CORPORATION (US) 1980-06-17 US claimed
WO-2023088470-A1 PROBIOTIC COMPOSITIONS FOR TREATMENT OF HAIR LOSS THE CHINESE UNIVERSITY OF HONG KONG (CN) 2023-05-25 WO disclosed
US-20170172957-A1 D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ALLERGAN, INC. 2017-06-22 US disclosed
EP-2714029-B1 D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ALLERGAN INC (US) 2017-04-12 EP disclosed
US-9415031-B2 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders ALLERGAN, INC. (US) 2016-08-16 US disclosed
US-20140221453-A1 D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS ALLERGAN, INC. (US) 2014-08-07 US disclosed
US-8741955-B2 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders ALLERGAN, INC. (US) 2014-06-03 US disclosed
US-8735451-B2 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders ALLERGAN, INC. (US) 2014-05-27 US disclosed
US-6387650-B1 INNOCULATING AND INCUBATING TEST SAMPLE ON GROWTH MEDIUM HAVING ENZYME SUBSTRATES FOR PHOSPHATASE, GLYCOSIDASE, AND PEPTIDASE, THEN DETECTING OR MEASURING SIGNAL PRODUCED BY THE HYDROLYSIS OF THE SUBSTRATES BIOCONTROL SYSTEMS, INC. 2002-05-14 US disclosed
EP-0165905-B1 DIAGNOSTIC ASSAY METHOD FOR THE DETECTION OF ORAL PATHOGENIC BACTERIA MIXTURES THE BOARD OF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1989-03-08 EP disclosed
EP-0122151-B1 PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE MEITO SANGYO KABUSHIKI KAISHA (JP) 1989-02-15 EP disclosed
US-4783402-A Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1988-11-08 US disclosed
EP-0122151-A2 Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1984-10-17 EP disclosed
US-4208480-A Method, reagents and apparatus for the rapid identification of Neisseria gonorrhoeae and Neisseria meningitidis AMERICAN HOME PRODUCTS CORPORATION (US) 1980-06-17 US disclosed
US-4208480-A Method, reagents and apparatus for the rapid identification of Neisseria gonorrhoeae and Neisseria meningitidis AMERICAN HOME PRODUCTS CORPORATION (US) 1980-06-17 US disclosed